DKK1 and breast carcinoma: MDA-MB-231_BH; DKK1 p < 0.0001, Vantictumab p < 0.0001) (Supplementary Fig. 2B), and in early breast cancer samples (DKK1; p = 0.0222, Vantictumab; p = 0.0060) (n = 10, Fig. 2c).